Literature DB >> 8841649

A non-parametric test for interval-censored failure time data with application to AIDS studies.

J Sun1.   

Abstract

Interest often centres on the comparison of failure time distributions based on interval-censored failure time data such as in the work by Finkelstein, in which she proposed a score test under continuous proportional hazards model. In this article, we consider a different situation in which the underlying failure time is a discrete variable or the observed times correspond with a discrete scale. To compare failure time distributions in these situations, we propose a non-parametric test, a generalization of the usual logrank test for right-censored failure time data. Simulation results indicate that the test performs satisfactorily.

Entities:  

Mesh:

Year:  1996        PMID: 8841649     DOI: 10.1002/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  25 in total

1.  Nonparametric test for doubly interval-censored failure time data.

Authors:  J Sun
Journal:  Lifetime Data Anal       Date:  2001-12       Impact factor: 1.588

2.  Nonparametric and Semiparametric Analysis of Current Status Data Subject to Outcome Misclassification.

Authors:  Victor G Sal Y Rosas; James P Hughes
Journal:  Stat Commun Infect Dis       Date:  2010-04-21

3.  A Randomized, Placebo-Controlled Trial of the Quadrivalent Human Papillomavirus Vaccine in Human Immunodeficiency Virus-Infected Adults Aged 27 Years or Older: AIDS Clinical Trials Group Protocol A5298.

Authors:  Timothy J Wilkin; Huichao Chen; Michelle S Cespedes; Jorge T Leon-Cruz; Catherine Godfrey; Elizabeth Y Chiao; Barbara Bastow; Jennifer Webster-Cyriaque; Qinghua Feng; Joan Dragavon; Robert W Coombs; Rachel M Presti; Alfred Saah; Ross D Cranston
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

4.  A new class of generalized log rank tests for interval-censored failure time data.

Authors:  Xingqiu Zhao; Ran Duan; Qiang Zhao; Jianguo Sun
Journal:  Comput Stat Data Anal       Date:  2013-04       Impact factor: 1.681

5.  Evidence of Early Emergence of the Primary Dentition in a Northern Plains American Indian Population.

Authors:  D V Dawson; D R Blanchette; J M Douglass; N Tinanoff; K W O Kramer; J J Warren; K R Phipps; D E Starr; T A Marshall; T R Mabry; K Pagan-Rivera; J A Banas; D R Drake
Journal:  JDR Clin Trans Res       Date:  2018-02-13

6.  Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.

Authors:  Norah A Terrault; R Todd Stravitz; Anna S F Lok; Greg T Everson; Robert S Brown; Laura M Kulik; Kim M Olthoff; Sammy Saab; Ovedele Adeyi; Curtis K Argo; Jay E Everhart; Del R Rodrigo
Journal:  Hepatology       Date:  2014-03-01       Impact factor: 17.425

7.  Weighted logrank tests for interval censored data when assessment times depend on treatment.

Authors:  Michael P Fay; Joanna H Shih
Journal:  Stat Med       Date:  2012-07-11       Impact factor: 2.373

8.  Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trial.

Authors:  Susan E Dorman; Radojka M Savic; Stefan Goldberg; Jason E Stout; Neil Schluger; Grace Muzanyi; John L Johnson; Payam Nahid; Emily J Hecker; Charles M Heilig; Lorna Bozeman; Pei-Jean I Feng; Ruth N Moro; William MacKenzie; Kelly E Dooley; Eric L Nuermberger; Andrew Vernon; Marc Weiner
Journal:  Am J Respir Crit Care Med       Date:  2015-02-01       Impact factor: 21.405

9.  Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

Authors:  Theodore E Warkentin; Richard J Cook; Victor J Marder; Jo-Ann I Sheppard; Jane C Moore; Bengt I Eriksson; Andreas Greinacher; John G Kelton
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

10.  Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package.

Authors:  Michael P Fay; Pamela A Shaw
Journal:  J Stat Softw       Date:  2010-08       Impact factor: 6.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.